Identification of Mutations Causing Aberrant Termination and Deficient Splice Donor Site on the HBA1 Gene

References

• Najmabadi H, Ghamari A, Sahebjam F, et al. Fourteen-year experience of prenatal diagnosis of thalassemia in Iran. Community Genet. 2006;9(2):93–97
   PubMedGoogle Scholar
• Hadavi V, Taromchi AH, Malekpour M, et al. Elucidating the spectrum of α-thalassemia mutations in Iran. Haematologica. 2007;92(7):992–993
   PubMed Web of Science ®Google Scholar
• Neishabury M, Oberkanins C, Moheb LA, et al. High prevalence of the –α3.7 deletion among thalassemia patients in Iran. Hemoglobin. 2003;27(1):53–55
   PubMed Web of Science ®Google Scholar
• Higgs DR. The molecular basis of α-thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, Eds. Disorders of Hemoglobin Genetics, Pathophysiology, and Clinical Management, 2nd ed. New York, NY: Cambridge University Press. 2009:241–265
   Google Scholar
• Kan YW. Molecular pathology of α-thalassemia. Ann N Y Acad Sci. 1985;445:28–36
   PubMed Web of Science ®Google Scholar
• Higgs DR, Vickers MA, Wilkie AOM, et al. A review of the molecular genetics of the human α-globin gene cluster. Blood. 1989;73(5):1081–1104
   PubMed Web of Science ®Google Scholar
• Giardine B, Borg J, Viennas E, et al. Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res. 2014;42(Database issue):1063–1069. (http://globin.cse.psu.edu)
   PubMed Web of Science ®Google Scholar
• Yuan J, Bunyaratvej A, Fucharoen S, et al. The instability of the membrane skeleton in thalassemic red blood cells. Blood. 1995;86(10):3945–3950
   PubMed Web of Science ®Google Scholar
• Schrier SL, Rachmilewitz E, Mohandas N. Cellular and membrane properties of α and β thalassemic erythrocytes are different: implication for differences in clinical manifestations. Blood. 1989;74(6):2194–2202
   PubMed Web of Science ®Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215
   PubMed Web of Science ®Google Scholar
• Farashi S, Vakili S, Garous NF, et al. Mutations on the α2-globin gene that may trigger α+-thalassemia. Hemoglobin . 2015;39(6):398–402
   Google Scholar
• Harteveld CL, Voskamp A, Phylipsen M, et al. Nine unknown rearrangements in 16p13.3 and 11p15.4 causing α- and β-thalassemia characterized by high resolution multiplex ligation-dependent probe amplification. J Med Genet. 2005;42(12):922–931
   PubMed Web of Science ®Google Scholar
• Harteveld CL, Refaldi C, Cassinerio E, et al. Segmental duplications involving the α-globin gene cluster are causing β-thalassemia intermedia phenotypes in β-thalassemia heterozygous patients. Blood Cells Mol Dis. 2008;40(3):312–316
   PubMed Web of Science ®Google Scholar
• Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248–249
   PubMed Web of Science ®Google Scholar
• Qadah T, Finlayson J, Ghassemifar R. In vitro characterization of the α-thalassemia point mutation HBA2:c.95 + 1G > A [IVS-I-1(G > A) (α2)]. Hemoglobin. 2012;36(1):38–46
   PubMed Web of Science ®Google Scholar
• Baserga SJ, Benz EJ Jr. Nonsense mutations in the human β-globin gene affect mRNA metabolism. Proc Natl Acad Sci USA. 1988;85(7):2056–2060
   PubMed Web of Science ®Google Scholar
• Thermann R, Neu-Yilik G, Deters A, et al. Binary specification of nonsense codons by splicing and cytoplasmic translation. EMBO J. 1998;17(12):3484–3494
   PubMed Web of Science ®Google Scholar
• Ayala S, Colomer D, Aymerich M, et al. First description of a frameshift mutation in the α1-globin gene associated with α-thalassaemia. Br J Haematol. 1997;98(1):47–50
   PubMed Web of Science ®Google Scholar
• Traeger-Synodinos J, Papassotiriou I, Metaxotou-Mavrommati A, et al. Distinct phenotypic expression associated with a new hyperunstable α globin variant (Hb Heraklion, α1cd37(C2)Pro > 0): Comparison to other α-thalassemic hemoglobinopathies. Blood Cells Mol Dis. 2000;26(4):276–284
   PubMed Web of Science ®Google Scholar
• Galacteros F, Girodon E, M’Rad A, et al. Hb Taybe (α38 or 39 THR deleted): An α-globin defect, silent in the heterozygous state and producing severe hemolytic anemia in the homozygous. C R Acad Sci III. 1994;317(5):437–444
   PubMed Web of Science ®Google Scholar
• Harteveld CL, Beijer C, van Delft P, et al. α-Thalassaemia as a result of a novel splice donor site mutation of the α1-globin gene. Br J Haematol. 2000;110(3):694–698
   PubMed Web of Science ®Google Scholar
• Cürük MA, Baysal E, Gupta RB, et al. An IVS-I-117 (G→A) acceptor splice site mutation in the α1-globin gene is a nondeletional α-thalassaemia-2 determinant in an Indian population. Br J Haematol. 1993;85(1):148–152
   PubMed Web of Science ®Google Scholar
• Waye JS, Eng B, Dutly F, Frischnecht H. α-Thalassemia caused by two novel splice mutations of the α2-globin gene: IVS-I-1 (G > A and G > T). Hemoglobin. 2009;33(6):519–522
   PubMed Web of Science ®Google Scholar
• Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: Exonic mutations that affect splicing. Nat Rev Genet. 2002;3(4):285–298
   PubMed Web of Science ®Google Scholar
• Ward AJ, Cooper TA. The pathobiology of splicing. J Pathol. 2010;220(2):152–163
   PubMed Web of Science ®Google Scholar
• Phylipsen M, Prior JF, Lim E, et al. Two new α1-globin gene point mutations: Hb Nedlands (HBA1:c.86C > T) [α28(B9)Ala→Val] and Hb Queens Park (HBA1:c.98T > A) [α32(B13)Met→Lys]. Hemoglobin. 2010;34(2):123–126
   PubMed Web of Science ®Google Scholar
• Harteveld KL, Heister JGAM, Giordano PC, et al. Rapid detection of point mutations and polymorphisms of the α-globin genes by DGGE and SSCA. Hum Mutat. 1996;7(2):114–122
   PubMed Web of Science ®Google Scholar
• Bayat N, Farashi S, Hafezi-Nejad N, et al. Novel mutations responsible for α-thalassemia in Iranian families. Hemoglobin. 2013;37(2):148–159
   PubMed Web of Science ®Google Scholar
• Harteveld CL, Versteegh FGA, Kok PJKJ, et al. Hb Bleuland [α108(G15)Thr→Asn, ACC→AAC (α2)]: A new abnormal hemoglobin associated with a mild α-thalassemia phenotype. Hemoglobin. 2006;30(3):349–354
   PubMed Web of Science ®Google Scholar
• Harteveld CL, Jebbink MCW, van der Lely N, et al. α-Thalassemia phenotype induced by the new IVS-II-2 (T→A) splice donor site mutation on the α2-globin gene. Hemoglobin. 2006;30(1):3–7
   PubMed Web of Science ®Google Scholar
• Felber BK, Orkin SH, Hamer DH. Abnormal RNA splicing causes one form of α thalassemia. Cell. 1982;29(3):895–902
   PubMed Web of Science ®Google Scholar
• Orkin SH, Goff SC, Hechtman RL. Mutation in an intervening sequence splice junction in man. Proc Natl Acad Sci USA. 1981;78(8):5041–5045
   PubMed Web of Science ®Google Scholar
• Wajcman H, Traeger-Synodinos J, Papassotiriou I, et al. Unstable and thalassemic α chain hemoglobin variants: A cause of Hb H disease and thalassemia intermedia. Hemoglobin. 2008;32(4):327–349
   PubMed Web of Science ®Google Scholar
• Arnon S, Tamary H, Dgany O, et al. Hydrops fetalis associated with homozygosity for Hemoglobin Taybe (α38/39 THR deletion) in newborn triplets. Am J Hematol. 2004;76(3):263–266
   PubMed Web of Science ®Google Scholar